메뉴 건너뛰기




Volumn 9, Issue 6, 2014, Pages 773-789

Combination therapy in severe Acinetobacter baumannii infections: An update on the evidence to date

Author keywords

Acinetobacter baumannii; antimicrobial resistance; clinical trials; combination therapy

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; COLISTIN; DAPTOMYCIN; DORIPENEM; FOSFOMYCIN; GALLIUM NITRATE; IMIPENEM; MEROPENEM; POLYMYXIN B; RIFAMPICIN; SULBACTAM; TEICOPLANIN; TELAVANCIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 84904603124     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.14.34     Document Type: Review
Times cited : (47)

References (98)
  • 1
    • 47949089607 scopus 로고    scopus 로고
    • Acinetobacter baumannii: Emergence of a successful pathogen
    • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21(3), 538-582 (2008
    • (2008) Clin. Microbiol. Rev , vol.21 , Issue.3 , pp. 538-582
    • Peleg, A.Y.1    Seifert, H.2    Paterson, D.L.3
  • 2
    • 79955611439 scopus 로고    scopus 로고
    • Global spread of multi-drug-resistant Acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance
    • Durante-Mangoni E, Zarrilli R. Global spread of multi-drug-resistant Acinetobacter baumannii: Molecular epidemiology and management of antimicrobial resistance. Future Microbiol. 6(4), 407-422 (2011
    • (2011) Future Microbiol , vol.6 , Issue.4 , pp. 407-422
    • Durante-Mangoni, E.1    Zarrilli, R.2
  • 3
    • 84857646835 scopus 로고    scopus 로고
    • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance
    • Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268-281 (2012
    • (2012) Clin. Microbiol. Infect , vol.18 , Issue.3 , pp. 268-281
    • Magiorakos, A.P.1    Srinivasan, A.2    Carey, R.B.3
  • 4
    • 84887666298 scopus 로고    scopus 로고
    • TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
    • Krizova L, Poirel L, Nordmann P, Nemec A. TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 68(12), 2786-2791 (2013
    • (2013) J. Antimicrob. Chemother , vol.68 , Issue.12 , pp. 2786-2791
    • Krizova, L.1    Poirel, L.2    Nordmann, P.3    Nemec, A.4
  • 5
    • 0343185958 scopus 로고    scopus 로고
    • Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii
    • Bou G, Martínez-Beltrán J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44(2), 428-432 (2000
    • (2000) Antimicrob. Agents Chemother , vol.44 , Issue.2 , pp. 428-432
    • Bou, G.1    Martínez-Beltrán, J.2
  • 6
    • 79251524206 scopus 로고    scopus 로고
    • Effect of frameshift mutagen acriflavine on control of resistance genes in Acinetobacter baumannii
    • Lopes BS, Hamouda A, Findlay J, Amyes SGB. Effect of frameshift mutagen acriflavine on control of resistance genes in Acinetobacter baumannii. J. Med. Microbiol. 60(Pt 2), 211-215 (2011
    • (2011) J. Med. Microbiol , vol.60 , Issue.PART 2 , pp. 211-215
    • Lopes, B.S.1    Hamouda, A.2    Findlay, J.3    Amyes, S.G.B.4
  • 7
    • 73849084148 scopus 로고    scopus 로고
    • Diversity, epidemiology and genetics of class D β-lactamases
    • Poirel L, Naas T, Nordmann P. Diversity, epidemiology and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54(1), 24-38 (2010
    • (2010) Antimicrob. Agents Chemother , vol.54 , Issue.1 , pp. 24-38
    • Poirel, L.1    Naas, T.2    Nordmann, P.3
  • 8
    • 33750586663 scopus 로고    scopus 로고
    • VEB-1 extended-spectrum β-lactamase producing Acinetobacter baumannii
    • Naas T, Coignard B, Carbonne A et al. VEB-1 extended-spectrum β-lactamase producing Acinetobacter baumannii, France. Emerg. Infect. Dis. 12(8), 1214-1222 (2006
    • (2006) France. Emerg. Infect. Dis , vol.12 , Issue.8 , pp. 1214-1222
    • Naas, T.1    Coignard, B.2    Carbonne, A.3
  • 9
    • 33748711682 scopus 로고    scopus 로고
    • Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas
    • Pasterán F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob. Agents Chemother. 50(9), 3222-3224 (2006
    • (2006) Antimicrob. Agents Chemother , vol.50 , Issue.9 , pp. 3222-3224
    • Pasterán, F.1    Rapoport, M.2    Petroni, A.3
  • 10
    • 34250191096 scopus 로고    scopus 로고
    • Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended spectrum β-lactamase
    • Endimiani A, Luzzaro F, Migliavacca R et al. Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended spectrum β-lactamase. Antimicrob Agents Chemother. 51(6), 2211-2214 (2007
    • (2007) Antimicrob Agents Chemother , vol.51 , Issue.6 , pp. 2211-2214
    • Endimiani, A.1    Luzzaro, F.2    Migliavacca, R.3
  • 11
    • 35448967975 scopus 로고    scopus 로고
    • Panresistant extended spectrum β-lactamase shv-5-producing acinetobacter baumannii from new york city
    • Naas T, Namdari F, R?glier-Poupet H, Poyart C, Nordmann P. Panresistant extended spectrum β-lactamase SHV-5-producing Acinetobacter baumannii from New York City. J. Antimicrob. Chemother. 60(5), 1174-1176 (2007
    • (2007) J. Antimicrob. Chemother , vol.60 , Issue.5 , pp. 1174-1176
    • Naas, T.1    Namdari, F.2    Réglier-Poupet, H.3    Poyart, C.4    Nordmann, P.5
  • 12
    • 4644315827 scopus 로고    scopus 로고
    • Nosocomial transmission of CTX-M-2 β lactamase producing Acinetobacter baumannii in a neurosurgery ward
    • Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. Nosocomial transmission of CTX-M-2 β lactamase producing Acinetobacter baumannii in a neurosurgery ward. J. Clin. Microbiol. 42(9), 3978-3984 (2004
    • (2004) J. Clin. Microbiol , vol.42 , Issue.9 , pp. 3978-3984
    • Nagano, N.1    Nagano, Y.2    Cordevant, C.3    Shibata, N.4    Arakawa, Y.5
  • 13
    • 11144280127 scopus 로고    scopus 로고
    • Dissemination and diversity of metallo-betalactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program
    • Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN. Dissemination and diversity of metallo-betalactamases in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25(1), 57-61 (2005
    • (2005) Int. J. Antimicrob. Agents , vol.25 , Issue.1 , pp. 57-61
    • Sader, H.S.1    Castanheira, M.2    Mendes, R.E.3    Toleman, M.4    Walsh, T.R.5    Jones, R.N.6
  • 14
    • 33744909136 scopus 로고    scopus 로고
    • VIM-1 metallo-beta-lactamase in Acinetobacter baumannii
    • Tsakris A, Ikonomidis A, Pournaras S et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg. Infect. Dis. 12(6), 981-983 (2006
    • (2006) Emerg. Infect. Dis , vol.12 , Issue.6 , pp. 981-983
    • Tsakris, A.1    Ikonomidis, A.2    Pournaras, S.3
  • 15
    • 27644562636 scopus 로고    scopus 로고
    • Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea
    • Lee K, Yum JH, Yong D et al. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49(11), 4485-4491 (2005
    • (2005) Antimicrob. Agents Chemother , vol.49 , Issue.11 , pp. 4485-4491
    • Lee, K.1    Yum, J.H.2    Yong, D.3
  • 16
    • 84865289239 scopus 로고    scopus 로고
    • Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe
    • Bonnin RA, Poirel L, Naas T et al. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 18(9), E362-E365 (2012
    • (2012) Clin. Microbiol. Infect , vol.18 , Issue.9
    • Bonnin, R.A.1    Poirel, L.2    Naas, T.3
  • 17
    • 80054691512 scopus 로고    scopus 로고
    • Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center
    • Espinal P, Fugazza G, López Y et al. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob. Agents Chemother. 55(11), 5396-5398 (2011
    • (2011) Antimicrob. Agents Chemother , vol.55 , Issue.11 , pp. 5396-5398
    • Espinal, P.1    Fugazza, G.2    López, Y.3
  • 20
  • 21
    • 33845450679 scopus 로고    scopus 로고
    • Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain
    • Siroy A, Cosette P, Seyer D et al. Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J. Proteome Res. 5(12), 3385-3398 (2006
    • (2006) J. Proteome Res , vol.5 , Issue.12 , pp. 3385-3398
    • Siroy, A.1    Cosette, P.2    Seyer, D.3
  • 22
    • 28844445544 scopus 로고    scopus 로고
    • Channel formation by CarO, the carbapenem resistance-Associated outer membrane protein of Acinetobacter baumannii
    • Siroy A, Molle V, Lemaitre-Guillier C et al. Channel formation by CarO, the carbapenem resistance-Associated outer membrane protein of Acinetobacter baumannii. Antimicrob. Agents Chemother. 49(12), 4876-4883 (2005
    • (2005) Antimicrob. Agents Chemother , vol.49 , Issue.12 , pp. 4876-4883
    • Siroy, A.1    Molle, V.2    Lemaitre-Guillier, C.3
  • 24
    • 0029035984 scopus 로고
    • Mutation in the gyrA gene of quinoloneresistant clinical isolates of Acinetobacter baumannii
    • Vila J, Ruiz J, Goñi P, Marcos A, de Anta TJ. Mutation in the gyrA gene of quinoloneresistant clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 39(5), 1201-1203 (1995
    • (1995) Antimicrob. Agents Chemother , vol.39 , Issue.5 , pp. 1201-1203
    • Vila, J.1    Ruiz, J.2    Goñi, P.3    Marcos, A.4    De Anta, T.J.5
  • 25
    • 0030851997 scopus 로고    scopus 로고
    • Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
    • Vila J, Ruiz J, Goni P, de Anta TJ. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J. Antimicrob. Chemother. 39(6), 757-762 (1997
    • (1997) J. Antimicrob. Chemother , vol.39 , Issue.6 , pp. 757-762
    • Vila, J.1    Ruiz, J.2    Goni, P.3    De Anta, T.J.4
  • 26
    • 9244250185 scopus 로고    scopus 로고
    • Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones
    • Nemec A, Dolzani L, Brisse S, van Den Broek P, Dijkshoorn L. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J. Med. Microbiol. 53(12), 1233-1240 (2004
    • (2004) J. Med. Microbiol , vol.53 , Issue.12 , pp. 1233-1240
    • Nemec, A.1    Dolzani, L.2    Brisse, S.3    Van Den Broek, P.4    Dijkshoorn, L.5
  • 27
    • 34547849631 scopus 로고    scopus 로고
    • Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China
    • Yu YS, Zhou H, Yang Q, Chen YG, Li LJ. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. J. Antimicrob. Chemother. 60(2), 454-455 (2007
    • (2007) J. Antimicrob. Chemother , vol.60 , Issue.2 , pp. 454-455
    • Yu, Y.S.1    Zhou, H.2    Yang, Q.3    Chen, Y.G.4    Li, L.J.5
  • 28
    • 77954753589 scopus 로고    scopus 로고
    • AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
    • Hornsey M, Ellington MJ, Doumith M et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J. Antimicrob. Chemother. 65(8), 1589-1593 (2010
    • (2010) J. Antimicrob. Chemother , vol.65 , Issue.8 , pp. 1589-1593
    • Hornsey, M.1    Ellington, M.J.2    Doumith, M.3
  • 29
    • 70349136689 scopus 로고    scopus 로고
    • Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system
    • Adams MD, Nickel GC, Bajaksouzian S et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 53(9), 3628-3634 (2009
    • (2009) Antimicrob. Agents Chemother , vol.53 , Issue.9 , pp. 3628-3634
    • Adams, M.D.1    Nickel, G.C.2    Bajaksouzian, S.3
  • 30
    • 79959261544 scopus 로고    scopus 로고
    • Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system
    • Beceiro A, Llobet E, Aranda J et al. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55(7), 3370-3379 (2011
    • (2011) Antimicrob. Agents Chemother , vol.55 , Issue.7 , pp. 3370-3379
    • Beceiro, A.1    Llobet, E.2    Aranda, J.3
  • 31
    • 84887274632 scopus 로고    scopus 로고
    • Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections
    • Lesho E, Yoon EJ, McGann P et al. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon During colistin therapy of wound infections. J. Infect. Dis. 208(7), 1142-1151 (2013
    • (2013) J. Infect. Dis , vol.208 , Issue.7 , pp. 1142-1151
    • Lesho, E.1    Yoon, E.J.2    McGann, P.3
  • 32
    • 84879590434 scopus 로고    scopus 로고
    • Clinical use of colistin induces crossresistance to host antimicrobials in Acinetobacter baumannii
    • Napier BA, Burd EM, Satola SW et al. Clinical use of colistin induces crossresistance to host antimicrobials in Acinetobacter baumannii. MBio 4(3), e00021-13 (2013
    • (2013) MBio , vol.4 , Issue.3
    • Napier, B.A.1    Burd, E.M.2    Satola, S.W.3
  • 33
    • 78649650250 scopus 로고    scopus 로고
    • Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production
    • Moffatt JH, Harper M, Harrison P et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54(12), 4971-4977 (2010
    • (2010) Antimicrob. Agents Chemother , vol.54 , Issue.12 , pp. 4971-4977
    • Moffatt, J.H.1    Harper, M.2    Harrison, P.3
  • 34
    • 0037378074 scopus 로고    scopus 로고
    • Epidemiology of rifampin adp-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaimp-4) gene cassettes in class 1 integrons in acinetobacter strains isolated from blood cultures in 1997 to 2000
    • Houang ET, Chu YW, Lo WS, Chu KJ, Cheng AF. Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob. Agents Chemother. 47(4), 1382-1390 (2003
    • (2003) Antimicrob. Agents Chemother , vol.47 , Issue.4 , pp. 1382-1390
    • Houang, E.T.1    Chu, Y.W.2    Lo, W.S.3    Chu, K.J.4    Cheng, A.F.5
  • 35
    • 82955162514 scopus 로고    scopus 로고
    • Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy
    • Giannouli M, Di Popolo A, Durante-Mangoni E et al. Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy. Int. J. Antimicrob. Agents 39(1), 58-63 (2012
    • (2012) Int. J. Antimicrob. Agents , vol.39 , Issue.1 , pp. 58-63
    • Giannouli, M.1    Di Popolo, A.2    Durante-Mangoni, E.3
  • 36
    • 84871664918 scopus 로고    scopus 로고
    • Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
    • Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents 41(1), 11-19 (2013
    • (2013) Int. J. Antimicrob. Agents , vol.41 , Issue.1 , pp. 11-19
    • Zarrilli, R.1    Pournaras, S.2    Giannouli, M.3    Tsakris, A.4
  • 37
    • 34147126025 scopus 로고    scopus 로고
    • Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy
    • Zarrilli R, Casillo R, Di Popolo A et al. Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy. Clin. Microbiol. Infect. 13(5), 481-489 (2007
    • (2007) Clin. Microbiol. Infect , vol.13 , Issue.5 , pp. 481-489
    • Zarrilli, R.1    Casillo, R.2    Di Popolo, A.3
  • 38
    • 77950471423 scopus 로고    scopus 로고
    • Molecular epidemiology of multi-drug resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone
    • Giannouli M, Cuccurullo S, Crivaro V et al. Molecular epidemiology of multi-drug resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J. Clin. Microbiol. 48(4), 1223-1230 (2010).
    • (2010) J. Clin. Microbiol , vol.48 , Issue.4 , pp. 1223-1230
    • Giannouli, M.1    Cuccurullo, S.2    Crivaro, V.3
  • 39
    • 84869211257 scopus 로고    scopus 로고
    • Clonal spread and patients' risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy
    • Zarrilli R, Di Popolo A, Bagattini M et al. Clonal spread and patients' risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J. Hosp. Infect. 82(4), 260-265 (2012
    • (2012) J. Hosp. Infect , vol.82 , Issue.4 , pp. 260-265
    • Zarrilli, R.1    Di Popolo, A.2    Bagattini, M.3
  • 40
    • 84885377048 scopus 로고    scopus 로고
    • Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community-And hospitalacquired urinary tract infections in Turkey
    • Demir T, Buyukguclu T. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community-And hospitalacquired urinary tract infections in Turkey. Int. J. Infect. Dis. 17(11), e966-e970 (2013
    • (2013) Int. J. Infect. Dis , vol.17 , Issue.11
    • Demir, T.1    Buyukguclu, T.2
  • 41
    • 57349139420 scopus 로고    scopus 로고
    • Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii
    • Adams MD, Goglin K, Molyneaux N et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J. Bacteriol. 190(24), 8053-8064 (2008
    • (2008) J. Bacteriol , vol.190 , Issue.24 , pp. 8053-8064
    • Adams, M.D.1    Goglin, K.2    Molyneaux, N.3
  • 42
    • 33748697027 scopus 로고    scopus 로고
    • Heteroresistance to colistin in multidrugresistant Acinetobacter baumannii
    • Li J, Rayner CR, Nation RL et al. Heteroresistance to colistin in multidrugresistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 50(9), 2946-2950 (2006
    • (2006) Antimicrob. Agents Chemother , vol.50 , Issue.9 , pp. 2946-2950
    • Li, J.1    Rayner, C.R.2    Nation, R.L.3
  • 43
    • 33747890430 scopus 로고    scopus 로고
    • Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam
    • Pachon-Ibanez ME, Fernandez-Cuenca F, Docobo-Perez F, Pachon J, Pascual A. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. J. Antimicrob. Chemother. 58(3), 689-692 (2006
    • (2006) J. Antimicrob. Chemother , vol.58 , Issue.3 , pp. 689-692
    • Pachon-Ibanez, M.E.1    Fernandez-Cuenca, F.2    Docobo-Perez, F.3    Pachon, J.4    Pascual, A.5
  • 44
    • 77149153364 scopus 로고    scopus 로고
    • Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii
    • Pachon-Ibanez ME, Docobo-Perez F, Lopez-Rojas L et al. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 54(3), 1165-1172 (2010
    • (2010) Antimicrob. Agents Chemother , vol.54 , Issue.3 , pp. 1165-1172
    • Pachon-Ibanez, M.E.1    Docobo-Perez, F.2    Lopez-Rojas, L.3
  • 45
    • 12344303247 scopus 로고    scopus 로고
    • Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
    • Montero A, Ariza J, Corbella X et al. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J. Antimicrob. Chemother. 54(6), 1085-1091 (2004
    • (2004) J. Antimicrob. Chemother , vol.54 , Issue.6 , pp. 1085-1091
    • Montero, A.1    Ariza, J.2    Corbella, X.3
  • 46
    • 1442324767 scopus 로고    scopus 로고
    • In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii
    • Yoon J, Urban C, Terzina C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48(3), 753-757 (2004
    • (2004) Antimicrob. Agents Chemother , vol.48 , Issue.3 , pp. 753-757
    • Yoon, J.1    Urban, C.2    Terzina, C.3    Mariano, N.4    Rahal, J.J.5
  • 47
    • 35748930554 scopus 로고    scopus 로고
    • Comparative activities of colistin, rifampicin, imipenem, sulbactam/ ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases
    • Tripodi M-F, Durante-Mangoni E, Fortunato R, Utili R, Zarrilli R. Comparative activities of colistin, rifampicin, imipenem, sulbactam/ ampicillin alone or in combination against epidemic multidrug-resistant. Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Int. J. Antimicrob. Agents 30(6), 537-540 (2007
    • (2007) Int. J. Antimicrob. Agents , vol.30 , Issue.6 , pp. 537-540
    • Tripodi, M.-F.1    Durante-Mangoni, E.2    Fortunato, R.3    Utili, R.4    Zarrilli, R.5
  • 48
    • 84884233320 scopus 로고    scopus 로고
    • Systematic review and meta-Analysis of in vitro synergy of polymyxins and carbapenems
    • Zusman O, Avni T, Leibovici L et al. Systematic review and meta-Analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob. Agents Chemother. 57(10), 5104-5111 (2013
    • (2013) Antimicrob. Agents Chemother , vol.57 , Issue.10 , pp. 5104-5111
    • Zusman, O.1    Avni, T.2    Leibovici, L.3
  • 49
    • 84876209645 scopus 로고    scopus 로고
    • Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains
    • O'Hara JA, Ambe LA, Casella LG et al. Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains. Antimicrob. Agents Chemother. 57(5), 2103-2108 (2013
    • (2013) Antimicrob. Agents Chemother , vol.57 , Issue.5 , pp. 2103-2108
    • O'hara, J.A.1    Ambe, L.A.2    Casella, L.G.3
  • 50
    • 84893488589 scopus 로고    scopus 로고
    • In vitro responses of Acinetobacter baumannii to two-And three-drug combinations following exposure to colistin and doripenem
    • Oleksiuk LM, Nguyen MH, Press EG et al. In vitro responses of Acinetobacter baumannii to two-And three-drug combinations following exposure to colistin and doripenem. Antimicrob. Agents Chemother. 58(2), 1195-1199 (2014
    • (2014) Antimicrob. Agents Chemother , vol.58 , Issue.2 , pp. 1195-1199
    • Oleksiuk, L.M.1    Nguyen, M.H.2    Press, E.G.3
  • 52
    • 84880260396 scopus 로고    scopus 로고
    • Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/ pharmacodynamic model
    • Lee HJ, Bergen PJ, Bulitta JB et al. Synergistic activity of colistin and rifampin combination against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacokinetic/ pharmacodynamic model. Antimicrob. Agents Chemother. 57(8), 3738-3745 (2013
    • (2013) Antimicrob. Agents Chemother , vol.57 , Issue.8 , pp. 3738-3745
    • Lee, H.J.1    Bergen, P.J.2    Bulitta, J.B.3
  • 53
    • 33845654311 scopus 로고    scopus 로고
    • Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: The significance of co-Administration of rifampicin
    • Pantopoulou A, Giamarellos-Bourboulis EJ, Raftogannis M et al. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: The significance of co-Administration of rifampicin. Int. J. Antimicrob. Agents 29(1), 51-55 (2007
    • (2007) Int. J. Antimicrob. Agents , vol.29 , Issue.1 , pp. 51-55
    • Pantopoulou, A.1    Giamarellos-Bourboulis, E.J.2    Raftogannis, M.3
  • 54
    • 79959214029 scopus 로고    scopus 로고
    • In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection
    • Hornsey M, Wareham DW. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 55(7), 3534-3537 (2011
    • (2011) Antimicrob. Agents Chemother , vol.55 , Issue.7 , pp. 3534-3537
    • Hornsey, M.1    Wareham, D.W.2
  • 55
    • 79954596970 scopus 로고    scopus 로고
    • In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
    • Wareham DW, Gordon NC, Hornsey M. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 66(5), 1047-1051 (2011
    • (2011) J. Antimicrob. Chemother , vol.66 , Issue.5 , pp. 1047-1051
    • Wareham, D.W.1    Gordon, N.C.2    Hornsey, M.3
  • 56
    • 84861173941 scopus 로고    scopus 로고
    • In vitro activity of telavancin in combination with colistin versus Gramnegative bacterial pathogens Antimicrob
    • Hornsey M, Longshaw C, Phee L, Wareham DW. In vitro activity of telavancin in combination with colistin versus Gramnegative bacterial pathogens Antimicrob. Agents Chemother. 56(6), 3080-3085 (2012
    • (2012) Agents Chemother , vol.56 , Issue.6 , pp. 3080-3085
    • Hornsey, M.1    Longshaw, C.2    Phee, L.3    Wareham, D.W.4
  • 57
    • 84872903587 scopus 로고    scopus 로고
    • In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection
    • Hornsey M, Phee L, Longshaw C, Wareham DW. In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection. Int. J. Antimicrob. Agents. 41(3), 285-287 (2013
    • (2013) Int. J. Antimicrob. Agents , vol.41 , Issue.3 , pp. 285-287
    • Hornsey, M.1    Phee, L.2    Longshaw, C.3    Wareham, D.W.4
  • 58
    • 84890569234 scopus 로고    scopus 로고
    • In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens
    • Phee L, Hornsey M, Wareham DW. In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 32(10), 1291-1294 (2013
    • (2013) Eur. J. Clin. Microbiol. Infect. Dis , vol.32 , Issue.10 , pp. 1291-1294
    • Phee, L.1    Hornsey, M.2    Wareham, D.W.3
  • 59
    • 84866039806 scopus 로고    scopus 로고
    • Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii
    • Mutlu Yilmaz E, Sunbul M, Aksoy A, Yilmaz H, Guney AK, Guvenc T. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents. 40(4), 332-336 (2012
    • (2012) Int. J. Antimicrob. Agents , vol.40 , Issue.4 , pp. 332-336
    • Mutlu Yilmaz, E.1    Sunbul, M.2    Aksoy, A.3    Yilmaz, H.4    Guney, A.K.5    Guvenc, T.6
  • 60
    • 84893505135 scopus 로고    scopus 로고
    • In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem resistant Acinetobacter baumannii
    • Hagihara M, Housman ST, Nicolau DP, Kuti JL. In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 58(2), 874-879 (2014
    • (2014) Antimicrob. Agents Chemother , vol.58 , Issue.2 , pp. 874-879
    • Hagihara, M.1    Housman, S.T.2    Nicolau, D.P.3    Kuti, J.L.4
  • 61
    • 84868012115 scopus 로고    scopus 로고
    • In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii
    • Antunes LC, Imperi F, Minandri F, Visca P. In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 56(11), 5961-5970 (2012
    • (2012) Antimicrob. Agents Chemother , vol.56 , Issue.11 , pp. 5961-5970
    • Antunes, L.C.1    Imperi, F.2    Minandri, F.3    Visca, P.4
  • 62
    • 80054933214 scopus 로고    scopus 로고
    • In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases
    • Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. Southeast Asian J. Trop. Med. Public Health 42(4), 890-900 (2011
    • (2011) Southeast Asian J. Trop. Med. Public Health , vol.42 , Issue.4 , pp. 890-900
    • Santimaleeworagun, W.1    Wongpoowarak, P.2    Chayakul, P.3    Pattharachayakul, S.4    Tansakul, P.5    Garey, K.W.6
  • 63
    • 33749246411 scopus 로고    scopus 로고
    • The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: Risk factors and outcomes
    • Robenshtok E, Paul M, Leibovici L et al. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: Risk factors and outcomes. J. Hosp. Infect. 64(3), 282-287 (2006
    • (2006) J. Hosp. Infect , vol.64 , Issue.3 , pp. 282-287
    • Robenshtok, E.1    Paul, M.2    Leibovici, L.3
  • 64
    • 33846116186 scopus 로고    scopus 로고
    • Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization
    • Sunenshine RH, Wright M-O, Maragakis LL et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 13(1), 97-103 (2007
    • (2007) Emerg. Infect. Dis , vol.13 , Issue.1 , pp. 97-103
    • Sunenshine, R.H.1    Wright, M.-O.2    Maragakis, L.L.3
  • 66
    • 33746093374 scopus 로고    scopus 로고
    • Attributable mortality of Acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies
    • Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: A systematic review of matched cohort and case-control studies. Crit. Care 10(2), R48 (2006
    • (2006) Crit. Care , vol.10 , Issue.2
    • Falagas, M.E.1    Bliziotis, I.A.2    Siempos, I.I.3
  • 67
    • 36448983944 scopus 로고    scopus 로고
    • Polimixin B for the treatment of multidrugresistant pathogens: A critical review
    • Zavascki AP, Goldani LZ, Li J, Nation RL. Polimixin B for the treatment of multidrugresistant pathogens: A critical review. J. Antimicrob. Chemother. 60(6), 1206-1215 (2007
    • (2007) J. Antimicrob. Chemother , vol.60 , Issue.6 , pp. 1206-1215
    • Zavascki, A.P.1    Goldani, L.Z.2    Li, J.3    Nation, R.L.4
  • 69
    • 33747362870 scopus 로고    scopus 로고
    • Colistin: The re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections
    • Li J, Nation RL, Turnidge JD et al. Colistin: The re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections. Lancet Infect. Dis. 6(9), 589-601 (2006
    • (2006) Lancet Infect. Dis , vol.6 , Issue.9 , pp. 589-601
    • Li, J.1    Nation, R.L.2    Turnidge, J.D.3
  • 71
    • 77957569216 scopus 로고    scopus 로고
    • Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration
    • Imberti R, Cusato M, Villani P et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration. Chest 138(6), 1333-1339 (2010
    • (2010) Chest , vol.138 , Issue.6 , pp. 1333-1339
    • Imberti, R.1    Cusato, M.2    Villani, P.3
  • 72
    • 78649823833 scopus 로고    scopus 로고
    • Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-Associated pneumonia: A matched case-control study
    • Kofteridis DP, Alexopoulou C, Valachis A et al. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-Associated pneumonia: A matched case-control study. Clin. Infect. Dis. 51(11), 1238-1244 (2010
    • (2010) Clin. Infect. Dis , vol.51 , Issue.11 , pp. 1238-1244
    • Kofteridis, D.P.1    Alexopoulou, C.2    Valachis, A.3
  • 73
    • 78149480085 scopus 로고    scopus 로고
    • Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-Associated pneumonia caused by Gram-negative bacteria
    • Rattanaumpawan P, Lorsutthitham J, Ungprasert P, Angkasekwinai N, Thamlikitkul V. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-Associated pneumonia caused by Gram-negative bacteria. J. Antimicrob. Chemother. 65(12), 2645-2649 (2010
    • (2010) J. Antimicrob. Chemother , vol.65 , Issue.12 , pp. 2645-2649
    • Rattanaumpawan, P.1    Lorsutthitham, J.2    Ungprasert, P.3    Angkasekwinai, N.4    Thamlikitkul, V.5
  • 74
    • 80054088449 scopus 로고    scopus 로고
    • Incidence of and risk factors for colistin-Associated nephrotoxicity in a large academic health system
    • Pogue JM, Lee J, Marchaim D et al. Incidence of and risk factors for colistin-Associated nephrotoxicity in a large academic health system. Clin. Infect. Dis. 53(9), 879-884 (2011
    • (2011) Clin. Infect. Dis , vol.53 , Issue.9 , pp. 879-884
    • Pogue, J.M.1    Lee, J.2    Marchaim, D.3
  • 75
    • 84880379313 scopus 로고    scopus 로고
    • Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii A multicentre, randomised, clinical trial
    • Durante-Mangoni E, Signoriello G, Andini R et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii. A multicentre, randomised, clinical trial. Clin. Infect. Dis. 57(3), 349-358 (2013
    • (2013) Clin. Infect. Dis , vol.57 , Issue.3 , pp. 349-358
    • Durante-Mangoni, E.1    Signoriello, G.2    Andini, R.3
  • 76
    • 0038369924 scopus 로고    scopus 로고
    • Treatment of multidrug-resistant Acinetobacter baumannii ventilator-Associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP
    • Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-Associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin. Infect. Dis. 36(9), 1111-1118 (2003
    • (2003) Clin. Infect. Dis , vol.36 , Issue.9 , pp. 1111-1118
    • Garnacho-Montero, J.1    Ortiz-Leyba, C.2    Jiménez-Jiménez, F.J.3
  • 77
    • 23744504983 scopus 로고    scopus 로고
    • Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study
    • Reina R, Estenssoro E, Sáenz G et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study. Intensive Care Med. 31(8), 1058-1065 (2005
    • (2005) Intensive Care Med , vol.31 , Issue.8 , pp. 1058-1065
    • Reina, R.1    Estenssoro, E.2    Sáenz, G.3
  • 78
    • 0032939527 scopus 로고    scopus 로고
    • Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii
    • Levin AS, Barone AA, Penço J et al. Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28(5), 1008-1011 (1999
    • (1999) Clin. Infect. Dis , vol.28 , Issue.5 , pp. 1008-1011
    • Levin, A.S.1    Barone, A.A.2    Penço, J.3
  • 79
    • 23044515861 scopus 로고    scopus 로고
    • Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
    • Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob. Agents Chemother. 49(8), 3136-3146 (2005
    • (2005) Antimicrob. Agents Chemother , vol.49 , Issue.8 , pp. 3136-3146
    • Kasiakou, S.K.1    Michalopoulos, A.2    Soteriades, E.S.3    Samonis, G.4    Sermaides, G.J.5    Falagas, M.E.6
  • 80
    • 50149096410 scopus 로고    scopus 로고
    • Colistin monotherapy vs. Combination therapy: Evidence from microbiological, animal and clinical studies
    • Petrosillo N, Ioannidou E, Falagas ME. colistin monotherapy vs. combination therapy: Evidence from microbiological, animal and clinical studies. Clin. Microbiol. Infect. 14(9), 816-827 (2008
    • (2008) Clin. Microbiol. Infect , vol.14 , Issue.9 , pp. 816-827
    • Petrosillo, N.1    Ioannidou, E.2    Falagas, M.E.3
  • 81
    • 74249103796 scopus 로고    scopus 로고
    • Rifampin combination therapy for nonmycobacterial infections
    • Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin. Microbiol. Rev. 23(1), 14-34 (2010
    • (2010) Clin. Microbiol. Rev , vol.23 , Issue.1 , pp. 14-34
    • Forrest, G.N.1    Tamura, K.2
  • 82
    • 33747874139 scopus 로고    scopus 로고
    • Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections
    • Saballs M, Pujol M, Tubau F et al. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections. J. Antimicrob. Chemother. 58(3), 697-700 (2006
    • (2006) J. Antimicrob. Chemother , vol.58 , Issue.3 , pp. 697-700
    • Saballs, M.1    Pujol, M.2    Tubau, F.3
  • 83
    • 22944482529 scopus 로고    scopus 로고
    • Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: Clinical outcome and adverse events
    • Petrosillo N, Chinello P, Proietti MF et al. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: Clinical outcome and adverse events. Clin. Microbiol. Infect. 11(8), 682-683 (2005
    • (2005) Clin. Microbiol. Infect , vol.11 , Issue.8 , pp. 682-683
    • Petrosillo, N.1    Chinello, P.2    Proietti, M.F.3
  • 84
    • 33745586136 scopus 로고    scopus 로고
    • Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
    • Motaouakkil S, Charra B, Hachimi A et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J. Infect. 53(4), 274-278 (2006
    • (2006) J. Infect , vol.53 , Issue.4 , pp. 274-278
    • Motaouakkil, S.1    Charra, B.2    Hachimi, A.3
  • 85
    • 38349181470 scopus 로고    scopus 로고
    • Colistin and rifampicin in the treatment of multidrugresistant Acinetobacter baumannii infections
    • Bassetti M, Repetto E, Righi E et al. Colistin and rifampicin in the treatment of multidrugresistant Acinetobacter baumannii infections. J. Antimicrob. Chemother. 61(2), 417-420 (2008
    • (2008) J. Antimicrob. Chemother , vol.61 , Issue.2 , pp. 417-420
    • Bassetti, M.1    Repetto, E.2    Righi, E.3
  • 86
    • 49749141456 scopus 로고    scopus 로고
    • Colistin and rifampicin combination in the treatment of ventilator-Associated pneumonia caused by carbapenem resistant Acinetobacter baumannii
    • Song JY, Lee J, Heo JY et al. Colistin and rifampicin combination in the treatment of ventilator-Associated pneumonia caused by carbapenem resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents 32(3), 281-284 (2008
    • (2008) Int. J. Antimicrob. Agents , vol.32 , Issue.3 , pp. 281-284
    • Song, J.Y.1    Lee, J.2    Heo, J.Y.3
  • 87
    • 33751091224 scopus 로고    scopus 로고
    • Effectiveness and nephrotoxicity of colistin monotherapy vs colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections
    • Falagas ME, Rafailidis PI, Kasiakou SK, Hatzopoulou P, Michalopoulos A. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin. Microbiol. Infect. 12(12), 1227-1230 (2006
    • (2006) Clin. Microbiol. Infect , vol.12 , Issue.12 , pp. 1227-1230
    • Falagas, M.E.1    Rafailidis, P.I.2    Kasiakou, S.K.3    Hatzopoulou, P.4    Michalopoulos, A.5
  • 88
    • 79955484275 scopus 로고    scopus 로고
    • Clinical implications of beta-lactam aminoglycoside synergism: Systematic review of randomised trials
    • Marcus R, Paul M, Elphick H, Leibovici L. Clinical implications of beta-lactam aminoglycoside synergism: Systematic review of randomised trials. Int. J. Antimicrob. Agents 37(6), 491-503 (2011
    • (2011) Int. J. Antimicrob. Agents , vol.37 , Issue.6 , pp. 491-503
    • Marcus, R.1    Paul, M.2    Elphick, H.3    Leibovici, L.4
  • 90
    • 0019921978 scopus 로고
    • Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study
    • Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann. Intern. Med. 97(4), 496-503 (1982
    • (1982) Ann. Intern. Med , vol.97 , Issue.4 , pp. 496-503
    • Korzeniowski, O.1    Sande, M.A.2
  • 91
    • 77954888053 scopus 로고    scopus 로고
    • Multiresistant Acinetobacter baumannii infections: Epidemiology and management
    • Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: Epidemiology and management. Curr. Opin. Infect. Dis. 23(4), 332-339 (2010
    • (2010) Curr. Opin. Infect. Dis , vol.23 , Issue.4 , pp. 332-339
    • Garnacho-Montero, J.1    Amaya-Villar, R.2
  • 92
    • 70849121220 scopus 로고    scopus 로고
    • Rifampicin combined regimens for Gram-negative infections: Data from the literature
    • Drapeau, CM, Grilli E, Petrosillo N. Rifampicin combined regimens for Gram-negative infections: Data from the literature. Int. J. Antimicrob. Agents 35(1), 39-44 (2010
    • (2010) Int. J. Antimicrob. Agents 35 , vol.1 , pp. 39-44
    • Drapeau, C.M.1    Grilli, E.2    Petrosillo, N.3
  • 93
    • 78649879211 scopus 로고    scopus 로고
    • How soon is now? the urgent need for randomized, controlled trials evaluating treatment of multidrugresistant bacterial infection
    • Paterson DL, Rogers BA. How soon is now?. The urgent need for randomized, controlled trials evaluating treatment of multidrugresistant bacterial infection. Clin. Infect. Dis. 51(11), 1245-1247 (2010
    • (2010) Clin. Infect. Dis , vol.51 , Issue.11 , pp. 1245-1247
    • Paterson, D.L.1    Rogers, B.A.2
  • 94
    • 84876933127 scopus 로고    scopus 로고
    • Colistin vs the combination of colistin and rifampicin for the treatment of carbapenemresistant Acinetobacter baumannii ventilatorassociated pneumonia
    • Aydemir H, Akduman D, Piskin N et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenemresistant Acinetobacter baumannii ventilatorassociated pneumonia. Epidemiol. Infect. 141(6), 1214-1222 (2013
    • (2013) Epidemiol. Infect , vol.141 , Issue.6 , pp. 1214-1222
    • Aydemir, H.1    Akduman, D.2    Piskin, N.3
  • 97
    • 84883465753 scopus 로고    scopus 로고
    • In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii
    • Thamlikitkul V, Tiengrim S. In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents. 42(3), 284-285 (2013
    • (2013) Int. J. Antimicrob. Agents , vol.42 , Issue.3 , pp. 284-285
    • Thamlikitkul, V.1    Tiengrim, S.2
  • 98
    • 84893471192 scopus 로고    scopus 로고
    • Colistin-glycopeptide combination in critically ill patients with Gram negative infection: The clinical experience
    • Petrosillo N, Giannella M, Antonelli M et al. Colistin-glycopeptide combination in critically ill patients with Gram negative infection: The clinical experience. Antimicrob. Agents Chemother. 58(2), 851-858 (2014
    • (2014) Antimicrob. Agents Chemother , vol.58 , Issue.2 , pp. 851-858
    • Petrosillo, N.1    Giannella, M.2    Antonelli, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.